Why consumers are crucial for building a sustainable health care system March 26, 2018 - 11:30 am to 3:45 pm 1777 F Street, NW Washington, DC 20006 ... Healthcare Transformation
Utilizing Innovative Statistical Methods and Trial Designs in Rare Disease Drug Development March 19, 2018 - 9:00 am to 5:00 pm Doubletree Hilton Silver Spring 8727 Colesville Road Silver Spring, MD 20910 Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and...
Public Workshop: Safety Assessment for Investigational New Drug Reporting March 8, 2018 - 9:00 am to 4:00 pm Council on Foreign Relations 1777 F Street NW Washington, DC 20006 This public workshop, convened under a cooperative agreement with the Food and Drug...
Public Workshop: Strategies for Promoting the Safe Use and Appropriate Prescribing of Prescription Opioids February 15, 2018 - 9:00 am to 4:30 pm National Press Club 529 14th Street NW, 13th Floor Washington, DC 20045 The current opioid epidemic remains a major public health crisis. In response to growing rates...
Assessing the Public Health Impact of Prescription Drug Postmarketing Safety Labeling Changes February 8, 2018 - 9:00 am to 4:00 pm Duke-Margolis Center for Health Policy 1201 Pennsylvania Avenue NW, Suite 500Washington, DC. 20004 When FDA identifies potential safety concerns with a medical product already on the market, it...
2018 Sentinel Initiative Annual Public Workshop February 7, 2018 - 9:00 am Hyatt Regency Bethesda 1 Bethesda Metro Center Bethesda, MD 20814 This annual workshop serves as a forum to bring together leading experts and interested...
Public Workshop: Oncology Clinical Trials in the Presence of Non-Proportional Hazards February 5, 2018 - 9:00 am to 4:30 pm National Press Club The National Press Club 529 14th St. NW, 13th Floor Washington, DC 20045 Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and...
FDA’s New Regulatory Framework for Tobacco and Nicotine: the Role of Medicinal Nicotine December 12, 2017 - 12:30 pm National Press Club 529 14th Street NW Washington, DC 20045 The U.S. Food and Drug Administration (FDA) recently announced a new, comprehensive regulatory...
Advancing Structured Benefit-Risk Assessment in FDA Review October 4, 2017 (All day) The Duke-Margolis Center for Health Policy 1201 Pennsylvania Avenue, NW, 5th Floor, Washington, DC 20004 As part of a broader effort to increase the predictability, transparency, and efficiency of its...
Exploring Approaches for Value-based Reimbursement of Oncology Therapies October 3, 2017 (All day) Duke-Margolis Center for Health Policy 1201 Pennsylvania Avenue NW, Suite 500 Washington, DC. 20004 Advances in cancer care have resulted in significant improvement in patient outcomes, but... Biomedical InnovationHealthcare Transformation
